| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




From the * Laboratory of Genetics, NIA-IRP,
Baltimore, Maryland;
División
Genética, Centro de Investigación Biomédica de Occidente,
CMNO-IMSS, Guadalajara, México;
Unita'
di Genetica Medica, Universita' di Modena, Modena, Italy; and
Istituto di Neurogenetica e Neurofarmacologia,
Consiglio Nazionale delle Ricerche, Cagliari, Italy.
| Correspondence to: Dr David Schlessinger, Laboratory of Genetics, National Institute on Aging, 251 Bayview Blvd, Baltimore, MD 21224 (e-mail: SchlessingerD{at}mail.nih.gov). |
The discovery that the SRY gene induces male sex in humans and
other mammals led to speculation about a possible equivalent for female sex.
But females are proving to be more complicated. Several master genes appear to
be autonomously involved, and female sex determination seems to remain
relatively labile. Partial loss of function of the transcription factor
FOXL2 leads to premature ovarian failure in women; and in animal
models, Foxl2 is required for folliculogenesis as well as for
maintenance, and possibly induction, of female sex determination. In the germ
line, oocytes apparently form normally even in the absence of Foxl2,
dependent on genes that include female-specific factors such as
Fig-alpha, Nobox, etc. In the soma, ablation of
Foxl2 or the independently expressed gene Wnt4 (likely
downstream of Rspo1) can produce partial testis differentiation in XX
mice, and the double knockout results in the formation of tubules and
spermatogonia. This indicates that at least 2 autonomous ovarian pathways are
required to antagonize testis differentiation in females, a finding that is
being increasingly corroborated by studies in goats and nonmammalian
vertebrates. In recent expression profiling of mouse ovaries that lack
Foxl2 alone or in combination with Wnt4 or
Kit/c-Kit, we found that following Foxl2 loss,
early testis genes (including the downstream effector of Sry,
Sox9) and several novel ovarian genes were consistently dysregulated
during embryo-fetal development. The results support the proposal of
dose-dependent Foxl2 function and antitestis action. A partial
working model for somatic development and sex determination is presented in
which Sox9 is a direct antagonist of Foxl2 in the supporting
cell lineage.
Key words: Sex determination, ovary, testis, Foxl2, sex reversal, gonadal development
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |